Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News
  • Published:

Prenatal-screening companies expand scope of DNA tests

But the increasingly accurate analyses carry the ethical dilemma of uncertain outcomes.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Authors

Related links

Related links

Related links in Nature Research

Fetal tests spur legal battle 2012-Jun-27

Fetal gene screening comes to market 2011-Oct-25

Growth of genome screening needs debate 2011-Aug-03

Blood test for Down's syndrome unveiled 2008-Oct-06

Fetal genetic testing: Screen test 2005-Dec-07

Related external links

International 22q11.2 Foundation

American College of Medical Genetics and Genomics on non-invasive prenatal screening (PDF)

American College of Obstetricians and Gynecologists on non-invasive prenatal screening

Rights and permissions

Reprints and permissions

About this article

Cite this article

Check Hayden, E. Prenatal-screening companies expand scope of DNA tests. Nature 507, 19 (2014). https://doi.org/10.1038/507019a

Download citation

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/507019a

This article is cited by

Search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research